Product Program year 2019 Source: CMS Open Payments

Defitelio

Drug Hematology

NDC 68727-800-02

Open in the dashboard

General payments

$594,733

984 payments

Research payments

$20,197,031

458 payments

Through program year 2019, $594,733 in general payments and $20,197,031 in research payments were reported against Defitelio (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $594,733 984
2019 Research $20,197,031 458

Breakdown

Who paid General payments · program year 2019
  1. Jazz Pharmaceuticals Inc. $594,733 984 payments
Top recipients General payments · program year 2019
  1. Kenneth Cooke Pediatric Hematology-Oncology · Baltimore, MD $72,956 12% · 93 payments
  2. David Margolis Pediatric Hematology-Oncology · Thiensville, WI $56,743 10% · 56 payments
  3. Ut Md Anderson Cancer Center Teaching hospital · TX $39,356 7% · 2 payments
  4. Mitchell Cairo Pediatric Hematology-Oncology · Hawthorne, NY $30,738 5% · 41 payments
  5. Amer Beitinjaneh Hematology & Oncology · Miami, FL $28,136 5% · 32 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pediatric Hematology-Oncology Pediatrics $263,132 47% · 128 practitioners
  2. Hematology & Oncology Internal Medicine $220,839 40% · 56 practitioners
  3. Hematology Internal Medicine $37,786 7% · 15 practitioners
  4. Medical Oncology Internal Medicine $15,023 3% · 10 practitioners
  5. Internal Medicine $11,663 2% · 5 practitioners

The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Maryland $88,320 15% · 11 recipients
  2. New York $78,593 13% · 31 recipients
  3. Texas $69,829 12% · 17 recipients
  4. Wisconsin $61,254 10% · 4 recipients
  5. Florida $54,472 9% · 19 recipients

The top 5 of 38 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

984 general · 458 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record